Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent

G Biesecker, E R Podack, C A Halverson

    The Journal of Experimental Medicine
    |February 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The molecular mechanism of lymphocyte-mediated tumor cell lysis.

    Immunology today·2014
    Same author

    Perforin-2 restricts growth of Chlamydia trachomatis in macrophages.

    Infection and immunity·2013
    Same author

    CD30L/CD30 is critical for maintenance of IL-17A-producing γδ T cells bearing Vγ6 in mucosa-associated tissues in mice.

    Mucosal immunology·2013
    Same author

    Cell-secreted Gp96-Ig-peptide complexes induce lamina propria and intraepithelial CD8+ cytotoxic T lymphocytes in the intestinal mucosa.

    Mucosal immunology·2009
    Same author

    RELATION OF A beta(1)-GLYCOPROTEIN OF HUMAN SERUM TO THE COMPLEMENT SYSTEM.

    The Journal of experimental medicine·2009
    Same author

    The c3-activator system: an alternate pathway of complement activation.

    The Journal of experimental medicine·2009
    Same journal

    Regulation of solid tumors by the peripheral nervous system.

    The Journal of experimental medicine·2026
    Same journal

    Friend or foe? IFNλ drives fibrosis.

    The Journal of experimental medicine·2026
    Same journal

    BAd-looking or CHarming: The two faces of BACH2.

    The Journal of experimental medicine·2026
    Same journal

    Bridging veins govern discrepancy of CSF efflux into dura mater in mice.

    The Journal of experimental medicine·2026
    Same journal

    Chimeric allergen receptor regulatory T cells suppress birch pollen allergic airway inflammation.

    The Journal of experimental medicine·2026
    Same journal

    Interferon-λ drives renal fibrosis by coordinating epithelial-fibroblast crosstalk.

    The Journal of experimental medicine·2026
    See all related articles

    The membrane attack complex (MAC) forms cell lesions, differing from fluid phase SC5b-9. This dimerized MAC structure can reinsert into membranes, mimicking complement-induced damage.

    Area of Science:

    • Immunology
    • Cell Biology
    • Biochemistry

    Background:

    • The complement system is crucial for innate immunity.
    • The terminal pathway of complement forms the membrane attack complex (MAC).
    • MAC mediates cell lysis by creating pores in target cell membranes.

    Purpose of the Study:

    • To characterize the structure and properties of the membrane attack complex (MAC) isolated from cell membranes.
    • To compare the MAC with the fluid phase terminal complement complex, SC5b-9.
    • To investigate the functional and morphological characteristics of the MAC in relation to complement-mediated cell damage.

    Main Methods:

    • Isolation of MAC from complement-lysed cells.
    • Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) for subunit analysis.

    Related Experiment Videos

  • Immunochemical analysis to confirm composition.
  • Sedimentation analysis (ultracentrifugation) to determine sedimentation coefficients.
  • Molecular weight determination.
  • Electron microscopy for ultrastructural analysis.
  • Reconstitution into phospholipid bilayers.
  • Main Results:

    • Isolated MAC and fluid phase SC5b-9 share identical subunit compositions, with MAC lacking S-protein.
    • MAC exhibits a sedimentation coefficient of 33.5 S and a molecular weight of 1.7 x 10^6 daltons, indicating it is a dimer of C5b-9 (23 S, 1.0 x 10^6 daltons).
    • The MAC dimer can convert to a monomer without subunit dissociation.
    • Electron microscopy reveals MAC possesses the characteristic morphology of complement-induced membrane lesions, unlike SC5b-9.
    • Reconstituted MAC into lipid bilayers mimics the appearance and orientation of natural complement lesions.

    Conclusions:

    • The membrane attack complex (MAC) exists as a dimer (C5b-9)2, distinct from the monomeric SC5b-9 fluid phase complex.
    • The dimeric MAC structure is responsible for the ultrastructural lesions observed in complement-mediated cell lysis.
    • The isolated MAC retains the ability to form membrane lesions upon reincorporation into lipid bilayers, validating its role in complement cytotoxicity.